"One patient every 6 days at each location for sev

"One patient every 6 days at each location for severe and one patient every 12 days at each location for critical seems a bit underwhelming."

Ok. But, how much faster is that than CD10 and CD12 was?

I hear the arguments that BIOMM is legit, but do we actually know they are better tham our CRO was in the US? Not to mention the fact that the US had substantially more cases.

I certainly hope that they are able to enroll more quickly than we were, I just haven't seen any reason to assume that they will.